Type 1 Diabetes Mellitus in the First Years of Life – Onset, Initial
                    Treatment, and Early Disease Course

J. Ziegler; S. R. Tittel; T. Biester; T. Kapellen; A. Dost; N. Rochow; D.Seick Barbarini; A. Böhle; A. Galler; R. W. Holl

doi:10.1055/a-2316-0512

Experimental and Clinical Endocrinology & Diabetes, Table of Contents

Exp Clin Endocrinol Diabetes 2024; 132(08): 432-442
DOI: 10.1055/a-2316-0512

Article

Type 1 Diabetes Mellitus in the First Years of Life – Onset, Initial Treatment, and Early Disease Course

J. Ziegler^#

¹University Hospital Tübingen, Department of Pediatric and Adolescent Medicine, Tübingen, Germany

,

S. R. Tittel^#

²University of Ulm, Institute for Epidemiology and Medical Biometry, ZIBMT, Ulm, Germany

³German Center for Diabetes Research e.V., Munich-Neuherberg, Germany

,

T. Biester

⁴Children's Hospital Auf der Bult, Hanover, Germany

,

T. Kapellen

⁵University Hospital Leipzig, Department of Pediatric and Adolescent Medicine, Leipzig, Germany

,

A. Dost

⁶University Hospital Jena, Department of Pediatric and Adolescent Medicine, Jena, Germany

,

N. Rochow

⁷University Hospital of Paracelsus Medical Private University, Department for Newborns, Children and Adolescents, Nuremberg, Germany

,

D.Seick Barbarini

⁸Landeskrankenhaus Feldkirch, Academic Teaching Hospital, Department of Pediatrics, Feldkirch, Austria

,

A. Böhle

⁹Wilhelmstift Children's Hospital, Hamburg, Germany

,

A. Galler

¹⁰Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Sozialpädiatrisches Zentrum, Paediatric Endocrinology and Diabetology, Berlin, Germany

,

R. W. Holl

²University of Ulm, Institute for Epidemiology and Medical Biometry, ZIBMT, Ulm, Germany

³German Center for Diabetes Research e.V., Munich-Neuherberg, Germany

› Author Affiliations

Abstract

Objective This study investigated the onset and the choice of treatment in children with very early onset of type 1 diabetes mellitus (T1D).

Methods The study included 5,763 patients from the German Diabetes Patient Follow-up registry with onset of T1D in the first 4 years of life from January 2010 – June 2022. The analysis included diabetes-specific parameters, anthropometric data, and mode of treatment at onset, within the first and second year of T1D. Three groups were compared according to age at onset (G1: 223 patients 6–<12 months, G2: 1519 patients 12–<24 months, G3: 4001 patients 24–48 months).

Results In 12.3% of all cases in childhood and adolescence, the incidence of diabetes in the first 4 years of life was rare. At the onset, clinical status was worse and diabetic ketoacidosis (DKA) rates were higher in G1 and G2 (52.3% and 46.5%, respectively) compared to G3 (27.3% (p<0.001)). G1 and G2 were significantly more likely to be treated with insulin pump therapy (CSII) 2 years after onset (98.1% and 94.1%, respectively)) compared to G3 (85.8%, p<0.001). Median HbA1c after 2 years did not differ between groups (G1: 7.27% (56.0 mmol/mol), G2: 7.34% (56.7 mmol/mol) and G3: 7.27% (56.0 mmol/mol)) or when comparing CSII vs MDI. The rate of severe hypoglycemia (SH) and DKA during the first 2 years of treatment did not differ among the three groups, ranging from 1.83–2.63/100 patient-years (PY) for DKA and 9.37–24.2/100 PY for SH. Children with T1D under 4 years of age are more likely to be diagnosed with celiac disease but less likely to have thyroiditis than older children with T1DM.

Conclusions Young children with T1D had high rates of DKA at onset and were predominantly treated with insulin pump therapy during the first 2 years. The median HbA1c for all three groups was<7.5% (58 mmol/mol) without increased risk of SH or DKA. The use of continuous glucose monitoring (CGM) was not associated with lower HbA1c in children under 48 months.

Keywords

diabetes - autoimmunity - thyroiditis - autoimmunity - antibodies - autoimmunity

Full Text

References

References
1 Quinn M, Fleischman A, Rosner B. et al. Characteristics at diagnosis of type 1 diabetes in children younger than 6 years. J Pediatr 2006; 148: 366-371
2 Bizzarri C, Benevento D, Ciampalini P. et al. Clinical presentation and autoimmune characteristics of very young children at the onset of type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2010; 23: 1151-1157
3 Komulainen J, Kulmala P, Savola K. et al. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 1999; 22: 1950-1955
4 Maahs DM, Hermann JM, DuBose SN. et al. Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries. Diabetologia 2014; 57: 1578-1585
5 Wolfsdorf JI, Glaser N, Agus M. et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes 2018; 19: 155-177
6 Voigt M, Straube S, Schmidt P. et al. Standard values for the weight gain in pregnancy according to maternal height and weight. Z Geburtshilfe Neonatol 2007; 211: 191-203
7 Group WMGRS. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl 2006; 450: 76-85
8 Craig ME, Prinz N, Boyle CT. et al. Response to comment on Craig et al. Prevalence of celiac disease in 52,721 youth with type 1 diabetes: International comparison across three continents. Diabetes Care 2017; 40: 1034-1040. Diabetes Care 2017; 40: e168-e169
9 Glaser N, Fritsch M, Priyambada L. et al. ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes 2022; 23: 835-856
10 Abraham MB, Karges B, Dovc K. et al. ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 2022; 23: 1322-1340
11 van den Boom L, Karges B, Auzanneau M. et al. Temporal trends and contemporary use of insulin pump therapy and glucose monitoring among children, adolescents, and adults with type 1 diabetes between 1995 and 2017. Diabetes Care 2019; 42: 2050-2056
12 Tauschmann M, Hermann JM, Freiberg C. et al. Reduction in diabetic ketoacidosis and severe hypoglycemia in pediatric type 1 diabetes during the first year of continuous glucose monitoring: A multicenter analysis of 3,553 subjects from the DPV registry. Diabetes Care 2020; 43: e40-e42
13 Karges B, Schwandt A, Heidtmann B. et al. Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. JAMA 2017; 318: 1358-1366
14 Turtinen M, Harkonen T, Parkkola A. et al. Sex as a determinant of type 1 diabetes at diagnosis. Pediatr Diabetes 2018; 19: 1221-1228
15 Gale EA, Gillespie KM. Diabetes and gender. Diabetologia 2001; 44: 3-15
16 Bendas A, Rothe U, Kiess W. et al. Trends in incidence rates during 1999-2008 and prevalence in 2008 of childhood type 1 diabetes mellitus in Germany--model-based national estimates. PLoS One 2015; 10: e0132716
17 Segerer H, Wurm M, Grimsmann JM. et al. Diabetic ketoacidosis at manifestation of type 1 diabetes in childhood and adolescence-incidence and risk factors. Dtsch Arztebl Int 2021; 118: 367-372
18 Holder M, Ehehalt S. Significant reduction of ketoacidosis at diabetes onset in children and adolescents with type 1 diabetes-The Stuttgart Diabetes Awareness Campaign, Germany. Pediatr Diabetes 2020; 21: 1227-1231
19 Kamrath C, Rosenbauer J, Tittel SR. et al. Frequency of autoantibody-negative type 1 diabetes in children, adolescents, and young adults during the first wave of the COVID-19 pandemic in Germany. Diabetes Care 2021; 44: 1540-1546
20 Kamrath C, Tittel SR, Kapellen TM. et al. Early versus delayed insulin pump therapy in children with newly diagnosed type 1 diabetes: Results from the multicentre, prospective diabetes follow-up DPV registry. Lancet Child Adolesc Health 2021; 5: 17-25
21 Sherr JL, Hermann JM, Campbell F. et al. Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: Comparison of results from three large, transatlantic paediatric registries. Diabetologia 2016; 59: 87-91
22 Albanese-O'Neill A, Grimsmann JM, Svensson AM. et al. Changes in HbA1c between 2011 and 2017 in Germany/Austria, Sweden, and the United States: A lifespan perspective. Diabetes Technol Ther 2022; 24: 32-41
23 Champakanath A, Akturk HK, Alonso GT. et al. Continuous glucose monitoring initiation within first year of type 1 diabetes diagnosis Is associated with improved glycemic outcomes: 7-year follow-up study. Diabetes Care 2022; 45: 750-753
24 de Bock M, Codner E, Craig ME. et al. ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr Diabetes 2022; 23: 1270-1276
25 Holder M, Ziegler R, Auzanneau M. et al. Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter. Aktualisierung 2023, S3-Leitlinie der DDG 2023 - AWMF-Registernummer 057-016 - Version 4. 2023.
26 Zeng B, Gao L, Yang Q. et al. Automated insulin delivery systems in children and adolescents with type 1 diabetes: A systematic review and meta-analysis of outpatient randomized controlled trials. Diabetes Care 2023; 46: 2300-2307
27 Ware J, Allen JM, Boughton CK. et al. Randomized trial of closed-loop control in very young children with type 1 diabetes. N Engl J Med 2022; 386: 209-219
28 Kimbell B, Rankin D, Hart RI. et al. Parents' experiences of using a hybrid closed-loop system (CamAPS FX) to care for a very young child with type 1 diabetes: Qualitative study. Diabetes Res Clin Pract 2022; 187: 109877
29 Kamrath C, Tittel SR, Dunstheimer D. et al. Early vs late histological confirmation of coeliac disease in children with new-onset type 1 diabetes. Diabetologia 2022; 65: 1108-1118
30 Kordonouri O, Klinghammer A, Lang EB. et al. Thyroid autoimmunity in children and adolescents with type 1 diabetes: A multicenter survey. Diabetes Care 2002; 25: 1346-1350
31 Spaans E, Schroor E, Groenier K. et al. Thyroid disease and type 1 diabetes in Dutch children: A nationwide study (Young Dudes-3). J Pediatr 2017; 187: 189-193 e181
32 Kuchlbauer V, Vogel M, Gausche R. et al. High birth weights but not excessive weight gain prior to manifestation are related to earlier onset of diabetes in childhood: 'Accelerator hypothesis' revisited. Pediatr Diabetes 2014; 15: 428-435
33 Joslin EP. The growth, development and prognosis of diabetic children. JAMA 1925; 85
34 Bruining GJ. Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes. Lancet 2000; 356: 655-656
35 Knerr I, Wolf J, Reinehr T. et al. The 'accelerator hypothesis': Relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus. Diabetologia 2005; 48: 2501-2504
36 Betts P, Mulligan J, Ward P. et al. Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: Testing the 'accelerator hypothesis' (2). Diabet Med 2005; 22: 144-151
37 Ljungkrantz M, Ludvigsson J, Samuelsson U. Type 1 diabetes: Increased height and weight gains in early childhood. Pediatr Diabetes 2008; 9: 50-56
38 Bonfig W, Kapellen T, Dost A. et al. Growth in children and adolescents with type 1 diabetes. J Pediatr 2012; 160: 900-903 e902
39 Bognetti E, Riva MC, Bonfanti R. et al. Growth changes in children and adolescents with short-term diabetes. Diabetes Care 1998; 21: 1226-1229
40 Karges B, Rosenbauer J, Holterhus PM. et al. Hospital admission for diabetic ketoacidosis or severe hypoglycemia in 31,330 young patients with type 1 diabetes. Eur J Endocrinol 2015; 173: 341-350